Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Western Drugs is a prominent Indian pharmaceutical company specializing in the large-scale manufacture of Vitamin B3 (Niacin and Niacinamide) and its related derivatives. Established in 1989 and headquartered in Udaipur, Rajasthan, the company has grown to become one of the largest producers of Niacinamide in India, serving the pharmaceutical, food, and animal feed sectors globally. The company operates state-of-the-art manufacturing facilities that are WHO-GMP certified and comply with international quality standards. Their business model focuses on the production of high-purity Active Pharmaceutical Ingredients (APIs) and fine chemicals, maintaining a strong export presence in over 40 countries. Western Drugs is recognized for its robust chemical synthesis capabilities and its role as a reliable supplier in the global nutritional and metabolic health supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Western Drugs.